Brotman Baty Institute for Precision Medicine Launches in Seattle
The Brotman Baty Institute for Precision Medicine combines the research strengths and capabilities of UW Medicine, Fred Hutchinson Cancer Research Center and Seattle Children’s
Jeffrey and Susan Brotman and Pam and Dan Baty have made a $50 million gift to create the Brotman Baty Institute for Precision Medicine that combines the research strengths and capabilities of UW Medicine, Fred Hutchinson Cancer Research Center and Seattle Children’s. This gift is, in part, a legacy: Jeff Brotman, Costco co-founder and long-time business leader, died Aug. 1, 2017.
Precision medicine is an approach to research and patient care that uses information gained by genetic or molecular profiling to optimize diagnoses, treatments and therapies for the individual patient. Collaborations among the institute’s three co-founding institutions will lead to new, personalized approaches to the prevention and treatment of diseases, both common and rare, that limit the lives of millions of people worldwide.
The gift, said Jeff Brotman’s friend and business associate Dan Baty, will be a lasting tribute to Brotman’s generosity and interest in furthering medicine to save lives and prevent disease and illness.
“What attracted Jeff to precision medicine is that it will be a total transformation of how doctors can treat and heal,” said Baty, healthcare innovator and founder of private equity firm Columbia Pacific Management. “And what attracted all of us is that the three partner organizations have the expertise and the collaborative culture to make precision medicine a success.”
Susan Brotman said Jeff thoroughly enjoyed his involvement with the University of Washington and UW Medicine. “He was excited about what precision medicine will accomplish in the prevention and treatment of diseases,” she said. “We are proud to establish the Institute for Precision Medicine with the Batys.”
Precision medicine was born out of groundbreaking international research that was completed more than a decade ago. The Human Genome Project essentially mapped the human genetic blueprint. For scientists, this discovery was the launch pad to understanding how greater knowledge about the functions of genes and proteins can radically change the field of medicine.
Jay Shendure, M.D., Ph.D, UW professor of genome sciences at UW Medicine and an investigator of the Howard Hughes Medical Institute, will direct the BBI Institute, which will create a network of research labs across UW Medicine, Fred Hutch and Seattle Children’s.
“We have only begun to understand how the approximately 3 billion letters in the human genome actively code all of the complexity in a human body and the role they play in determining our health,” said Shendure. “There are exciting revolutions going on right now that are leading us toward a future where the ways we interact with the healthcare system will be highly tailored to who we are as individuals, genetically and otherwise.”
Researchers at the institute will focus on discoveries that will improve patient outcomes while minimizing the harmful side effects of treatments and therapies. Among the institute’s first projects is an effort to catalog the roughly 60,000 estimated possible mutations of the BRCA1 and BRCA2 genes —to identify those that confer the greatest risk of breast cancer — to help young women make informed decisions about their health.
“A typical patient doesn’t really exist, yet for more than a century, medicine has been focused on diagnosing and treating typical patients,” Shendure said. “Precision medicine aims to use an individual patient’s unique genetic code to more effectively diagnose and individually treat that person. Through both basic science and the translation of new advances to the clinic, the institute will accelerate this process.”
“This tremendous investment in precision medicine is truly an investment in the health of our community,” said Jeff Sperring, M.D., chief executive officer of Seattle Children’s. “We are proud to collaborate with UW Medicine and Fred Hutch as we work to advance new discoveries and treatments to help every child live the healthiest and most fulfilling life possible.”
Precision medicine research is gaining momentum because it leverages advances like the availability of inexpensive DNA sequencing technologies, the ability to effectively edit genomes, the ubiquity of mobile devices for capturing health information, the vast quantities of electronic health records and recent improvements in artificial intelligence, to name a few.
“Our collaborative effort is putting our region at the forefront of finding cures for cancer,” said Gary Gilliland, M.D., Ph.D., president and director of Fred Hutch. “With the convergence of bioscience, technology and data science, the three of us — Fred Hutch, Seattle Children’s and UW Medicine — are working together and with organizations across Washington to revolutionize cancer treatment. The vision and generosity of the Brotmans and Batys bring us closer to eliminating the suffering these and other diseases cause.”
“This commitment from the Brotmans and the Batys is an act of tremendous generosity,” said Paul G. Ramsey, M.D., CEO of UW Medicine. “It’s also a strategic investment in the ability of our organizations to use data and research to improve lives here and globally. The work will have a lasting impact on the future of medicine.”
About UW Medicine
UW Medicine is one of the top-rated academic medical systems in the world. With a mission to improve the health of the public, UW Medicine educates the next generation of physicians and scientists, leads one of the world’s largest and most comprehensive biomedical research programs, and provides outstanding care to patients from across the globe. UW School of Medicine faculty members are second in the nation in receipt of federal research grants and contracts, with $749.9 million in total revenue (fiscal year 2016) according to the Association of American Medical Colleges.
About Fred Hutchinson Cancer Research Center
At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network.
About Seattle Children’s
Seattle Children’s mission is to provide hope, care and cures to help every child live the healthiest and most fulfilling life possible. Together, Seattle Children’s Hospital, Research Institute and Foundation deliver superior patient care, identify new discoveries and treatments through pediatric research, and raise funds to create better futures for patients.
Ranked as one of the top children’s hospitals in the country by U.S. News & World Report, Seattle Children’s serves as the pediatric and adolescent academic medical center for Washington, Alaska, Montana and Idaho – the largest region of any children’s hospital in the country. As one of the nation’s top five pediatric research centers, Seattle Children’s Research Institute is internationally recognized for its work in neurosciences, immunology, cancer, infectious disease, injury prevention and much more. Seattle Children’s Foundation, along with Seattle Children’s Guild Association – the largest all volunteer fundraising network for any hospital in the country – works with our generous community to raise funds for lifesaving care and research.